InvestorsHub Logo

bobshmob

07/16/20 1:34 PM

#94727 RE: ombowstring #94709

If you start with 1 primary outcome and 17 secondary outcomes but are allowed to change the primary outcome to whichever of the secondary outcomes you like late, late in the trial, then there'd be a 1-0.95^18 = 60% chance that the chicken soup would show a "significant effect" ...just like remdesivir did.

I suspect leronlimab will show p < 0.05 on primary outcome and most of the secondary outcomes.

Venture_Cap

07/16/20 1:58 PM

#94731 RE: ombowstring #94709

Actually if you ask Chris Cuomo Chicken soup is the only therapeutic that worked that he had access to.

There is a science to it and yes it's got a better safety efficacy than Remdesivir. Facts matter.

https://journal.chestnet.org/article/S0012-3692(20)30870-9/pdf

Leronlimab does work better than both per EIND's.

ohm20

07/16/20 4:49 PM

#94779 RE: ombowstring #94709

You may be right. There have been studies that traditional Jewish chicken soup made with chicken feet can reduce the effects of the common cold due to the cartilage.